Slow-Release Nicotinic Acid has 2 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Levothyroxine Sodium, Liothyronine Sodium. Patients taking Slow-Release Nicotinic Acid should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 2
Moderate: 2

Moderate (2)

Slow-Release Nicotinic Acid + Levothyroxine Sodium— May decrease serum thyroxine-binding globulin concentration, resulting in initial transient increase in FT4 followed by …
Slow-Release Nicotinic Acid + Liothyronine Sodium— May decrease serum thyroxine-binding globulin concentration, altering T3 serum transport. Closely monitor thyroid hormon…

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.